Navigation Links
Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference

ditional potential to effectively treat avian flu in those already infected."

About Hemispherx Biopharma

Hemispherx Biopharma, Inc. is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx's flagship products include Alferon N Injection(R) and the experimental therapeutics Ampligen(R) and Oragens(R). Alferon N Injection(R) is approved for a category of STD infection, and Ampligen(R) and Oragens(R) represent experimental RNA nucleic acids being developed for globally important viral diseases and disorders of the immune system. Hemispherx's platform technology includes large and small agent components for potential treatment of various severely debilitating and life threatening diseases. Hemispherx has in excess of 100 patents comprising its core intellectual property estate, a fully commercialized product (Alferon N Injection(R)) and GMP certified manufacturing facilities for its novel pharma products. For more information please visit www.hemispherx.net.

Information contained in this news release other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risk of competition, changing market conditions, change in laws and regulations affecting these industries and numerous other factors discussed in this release and in the Company's filings with the Securities and Exchange Commission. Any specifically referenced investigational drugs and associated technologies of the Company (including Ampligen(R), Alferon LDO and Oragens) are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgment as of the date of
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Hemispherx Presents Evidence of Ampligen Synergies with Existing Antivirals at International Avian Influenza Conference
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
(Date:8/29/2014)... -- In part four of a blog series ... a strategic asset, Mary Baxter, MBA, RPh ., ... Innovation Delivery Solutions business, discusses how expanding patient access ... patients. "Every hospital pharmacist knows that filling ... in a value-based healthcare world," Baxter says. "For the ...
(Date:8/29/2014)... , August 29, 2014 ... and collaboration software has announced a major new deal ... founded by renowned pathology expert, Dr. Marius Nap ... of the 26th European Congress of Pathology which is ... the ExCeL Arena, London where ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
... N.J., April 3, 2012  Savient Pharmaceuticals, Inc. (NASDAQ: ... Vice President and President North American Commercial Operations, will ... Tuesday, April 17th, 2012 at 11:30 AM Eastern Time.  ... Palace Hotel, New York, NY. A live ...
...  AVT, Inc., (Ticker: AVTC) ( www.autoretail.com ), is a ... designed for use in hospitals, pharmacies, medical offices and ... to reduce and even eliminate prescription medicine dispensing errors. ... Journal of Pharmacy Practice reviewed 60 research papers that ...
Cached Medicine Technology:Savient Pharmaceuticals to Present at the Imperial Capital Healthcare Investor Forum 2Automated Medicine Dispensing Units Developed by AVT Can Reduce Errors 2
(Date:8/30/2014)... Albany, New York (PRWEB) August 30, 2014 ... a combination of Nutrition and Pharameuticals. Nutraceuticals is ... by extracting healthy ingredients from natural food sources. ... specific health benefits to the human body. Nutraceutical ... multivitamins, diet supplements, fortified foods and more. Although ...
(Date:8/30/2014)... August 30, 2014 The establishment ... planet has been one of the main strategies ... create a positive impact around the world. , ... with top trained executives and trainers deliver L. ... worldwide. Vital statistics demonstrate that significant reduction ...
(Date:8/30/2014)... Market Research Report on Global ... professional and in-depth market survey on Global and ... the basic information of Cell Disruptor including its ... explores global and China’s top manufacturers of Cell ... and market share etc. The report further analyzes ...
(Date:8/30/2014)... Manhattan Beach, Calif. (PRWEB) August 30, 2014 ... Carol Francis helps listeners understand how they unknowingly developed insomnia ... and have restful nights during. Tune in to the ... . The show airs live on August 30, and ... For more information on programming, go to DrCarolFrancisTalkRadio.com. ...
(Date:8/30/2014)... August 30, 2014 In today’s world, a ... to get. Snoring and sleep apnea (a medical problem where ... and their bed partners of the rest they need to ... the population snores and 20 million people in the United ... been diagnosed and treated; and of those treated, many cannot ...
Breaking Medicine News(10 mins):Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 3Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 4Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... Executive Officer, Effective January 1, ... ... today announced a leadership transition plan under which Michael P.,Kaminski, currently President ... title and responsibilities of Chief Executive,Officer, effective January 1, 2009. At that ...
... According to the American Diabetes,Association, 23.6 million Americans ... of the groups hardest hit by this disease, ... Diabetes Month,Black Expressions(R) Book Club has put together ... offer information about prevention, nutrition,and diet tips., ...
... Average psychiatrist salary increased for 60 percent of survey respondents. ... ... research by physician recruiting firm LocumTenens.com indicates that among the medical ... least to lose if universal healthcare coverage is implemented under the ...
... rehab facility located in Malibu, recently celebrated its fourth anniversary with ... a party for current and past residents. , ... ... rehab facility located in Malibu, recently celebrated its fourth anniversary with ...
... study finds that recent progress in closing the gap ... may be due primarily to smoking-related cancers, and that ... still be increasing. The study, appearing in the November ... is the first to analyze racial and ethnic differences ...
... Percent Increase in IVUS System Sales, SAN DIEGO, ... a leader in the development, manufacturing and sales of,products ... artery,disease, today reported that revenues for the third quarter ... quarter of 2007., For the quarter ended September ...
Cached Medicine News:Health News:Stereotaxis Announces New Management Appointment 2Health News:Stereotaxis Announces New Management Appointment 3Health News:National Diabetes Month Book Suggestions From Black Expressions(R) Book Club 2Health News:LocumTenens.com Finds Psychiatrists are Neutral on Universal Healthcare 2Health News:LocumTenens.com Finds Psychiatrists are Neutral on Universal Healthcare 3Health News:Malibu Alcohol and Drug Rehab Center Celebrates Fourth Anniversary 2Health News:Study finds racial disparities increasing for cancers unrelated to smoking 2Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 2Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 3Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 4Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 5Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 6Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 7Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 8Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 9Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 10Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 11Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 12Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 13Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 14
World's first commercially available vacuum assisted biopsy device for MRI....
... Now you can perform stereotactic, ultrasound and ... convenience of your office. Use the patented, ... easier and more clinically advanced method of ... best for the women who trust YOU.,12 ...
... perform stereotactic, ultrasound and MRI-guided vacuum assisted ... office. Use the patented, FDA-cleared ATEC system ... clinically advanced method of breast biopsy. Its ... women who trust YOU.,9 Gauge Handpieces: Useful ...
36" Penrose drains...
Medicine Products: